|
0
|
|
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
(journals.asm.org)
|
Kang HJ
…
Johnson MG
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#infection
#clinical trial
#antifungal
#aspergillosis
#pediatric
|
|
0
|
|
25 years of improvement in mortality in invasive aspergillosis in haematology patients: will it be sustained or is it under threat?
(academic.oup.com)
|
Maertens JA
…
Slavin MA
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#infection
#immunosuppression
#antifungal
#aspergillosis
#hematology
|
|
0
|
|
Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development.
(journals.asm.org)
|
Lepak A
…
Andes D
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#infection
#amr
#aspergillosis
|
|
0
|
|
Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.
(academic.oup.com)
|
Maertens J
…
Rex JH
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#antifungal
#aspergillosis
#drug-drug interaction
#salvage therapy
#invasive infection
|